Caleb Clifford May 21, 2021
Bionano Genomics Inc. [NASDAQ: BNGO] traded at a low on 07/23/21, posting a -3.08 loss after which it closed the day’ session at $5.97. The company report on July 19, 2021 that Bionano’s Optical Genome Mapping for Acute Lymphoblastic Leukemia Subjects at the University Hospitals Leuven, Belgium, Has Faster Turnaround Time, Higher Success Rates and Lower Cost per Sample Compared to Traditional Methods.
Bionano Genomics, Inc. (Nasdaq: BNGO) announces a summary of the results obtained by the University Hospitals Leuven, Belgium with optical genome mapping (OGM) with Bionano’s Saphyr® system. An assay was developed for whole genome analysis of acute lymphoblastic leukemia (ALL) subjects which, relative to traditional methods, resulted in a workflow with significantly faster turnaround time, higher success rates, and lower cost per sample. The key benefits of their OGM-based assay, as presented by Dr. Barbara Dewaele, are summarized below:.
Bionano Genomics Announces a Record Number of Optical Genome Mapping Presentations Scheduled to Appear at the Annual Cancer Genomics Consortium Meeting from August 1st
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Bionano Genomics Announces Significant Progress in China with WeHealth Shanghai s Adoption of Bionano s Saphyr System and the Demonstration by Various Institutions of Optical Genome Mapping in Rep
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Bionano Genomics Announces Back-to-Back Publications in the
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Posted on
FinancialBuzz.com’s latest
The Buzz Show: Featuring Our Corporate News Recap on “Bionano Genomics, Inc. up 6% after Becoming a Member of US Small-Cap Russell 2000® Index”
Bionano Genomics, Inc. (NASDAQ: BNGO) gained over 6% in premarket trading after the Company said it was added as a member of the US small-cap Russell 2000® Index, effective as of the Market open on June 28th.
Membership in the Russell 2000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index, with the indexes widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.